Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Praveen Thokala's publication output changed over time?
ScholarIQpublication output · 2012–2021
Output declined50% over the shown period — from 2 works in 2012 to 1 in 2021.
2
2
1
2
1
1
1
2012201320152016201820192021
What are the most-cited papers on Praveen Thokala?
ScholarIQmost cited works
Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
Praveen Thokala, Nancy Devlin, Kevin Marsh, Rob Baltussen, Meindert Boysen, Zoltán Kaló, Thomas Longrenn, Filip Mussen, Stuart Peacock, John B. Watkins, Maarten J. IJzerman
Value in Health. 2016738 CitationsOPEN ACCESS
Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
Kevin Marsh, Maarten J. IJzerman, Praveen Thokala, Rob Baltussen, Meindert Boysen, Zoltán Kaló, Thomas Lönngren, Filip Mussen, Stuart Peacock, John B. Watkins, Nancy Devlin
Value in Health. 2016476 CitationsOPEN ACCESS
Multiple Criteria Decision Analysis for Health Technology Assessment
Praveen Thokala, Alejandra Duenas
Value in Health. 2012329 CitationsOPEN ACCESS
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Mark Bond, G Rogers, J Peters, Rodney P. Anderson, Martin Hoyle, A Miners, T Moxham, Sarah Davis, Praveen Thokala, Allan Wailoo, Mona Jeffreys, Christopher Hyde
Health Technology Assessment. 2012307 CitationsOPEN ACCESS
Cost-Effectiveness Thresholds: the Past, the Present and the Future
Praveen Thokala, Jessica Ochalek, Ashley A. Leech, Thaison Tong
PharmacoEconomics. 2018201 CitationsOPEN ACCESS
Related on ScholarIQ
University of Sheffield
Institution
Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
Paper
Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
Paper
Multiple Criteria Decision Analysis for Health Technology Assessment
Paper
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Paper
Cost-Effectiveness Thresholds: the Past, the Present and the Future
Paper